Since the inhibition of TCR signaling had been demonstrated to overcome the resistance to chemotherapy in T cell lymphomas [60], the antitumor effects of the ITK inhibitor and conventional chemotherapies were further investigated in our experiment. Here, ITK is linked to T-cell non-Hodgkin lymphoma.